abexinostat formerly experimental drug candidate cancer developed pharmacyclics licensed xynomic phase ii clinical trials bcell preclinical study suggests potential treatment different types cancer abexinostat exerts effect panhistone deacetylase inhibits involved repairing dna double strand antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikiabexinostat